Fluoxetine targets early progenitor cells in the adult brain.
Chronic treatment with antidepressants increases neurogenesis in the adult hippocampus. This increase in the production of new neurons may be required for the behavioral effects of antidepressants. However, it is not known which class of cells within the neuronal differentiation cascade is targeted by the drugs. We have generated a reporter mouse line, which allows identification and classification of early neuronal progenitors. It also allows accurate quantitation of changes induced by neurogenic agents in these distinct subclasses of neuronal precursors. We use this line to demonstrate that the selective serotonin reuptake inhibitor antidepressant fluoxetine does not affect division of stem-like cells in the dentate gyrus but increases symmetric divisions of an early progenitor cell class. We further demonstrate that these cells are the sole class of neuronal progenitors targeted by fluoxetine in the adult brain and suggest that the fluoxetine-induced increase in new neurons arises as a result of the expansion of this cell class. This finding defines a cellular target for antidepressant drug therapies.
Encinas
Juan M
JM
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Vaahtokari
Anne
A
Enikolopov
Grigori
G
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002454:Cell Differentiation; D018891:Dentate Gyrus / Q000378:metabolism*; D005473:Fluoxetine / Q000494:pharmacology*; D051379:Mice; D008822:Mice, Transgenic; D008938:Mitosis; D008954:Models, Biological; D009474:Neurons / Q000378:metabolism*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology; D013234:Stem Cells / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism
D000928:Antidepressive Agents; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors